학술논문
Hearing Rehabilitation in Vestibular Schwannoma.
Document Type
Academic Journal
Author
Mankekar G; Department of Otolaryngology, Louisiana State Health University Sciences Center, Shreveport, LA 71103, USA.; Holmes S; Department of Otolaryngology, Cox Health Medical Group, Springfield, MO 35807, USA.
Source
Publisher: MDPI Country of Publication: Switzerland NLM ID: 101644681 Publication Model: Electronic Cited Medium: Print ISSN: 2039-4330 (Print) Linking ISSN: 20394330 NLM ISO Abbreviation: Audiol Res Subsets: PubMed not MEDLINE
Subject
Language
English
ISSN
2039-4330
Abstract
The most common complaint among patients with vestibular schwannoma (VS) is hearing loss. This significantly affects the quality of life before, during, and after treatment for patients with VS. Untreated hearing loss in VS patients may even lead to depression and feelings of social isolation. A variety of devices are available for hearing rehabilitation for patients with vestibular schwannoma. These include contralateral routing of hearing signals (CROSs), bone-anchored hearing devices, auditory brainstem implants (ABI), and cochlear implants. In the United States, ABI is approved for patients 12 years of age and older with neurofibromatosis type 2. In the past few years, cochlear implantation has been offered simultaneously or sequentially with tumor resection or irradiation, or even to patients whose VS have been monitored with serial imaging. However, determining the functional integrity of the auditory nerve in patients with vestibular schwannoma is a challenge. This review article consists of (1) the pathophysiology of vestibular schwannoma (VS), (2) hearing loss in VS, (3) treatment of VS and associated hearing loss, (4) options for auditory rehabilitation in patients with VS with their individual benefits and limitations, and (5) challenges in hearing rehabilitation in this cohort of patients to determine auditory nerve functionality. (6) Future directions.